Gilead Sciences Inc. CDR (GILD)
Market Closed
12 Jun, 20:00
NEO-L NEO-L Primary TSX CA$
25. 42
-0.17
-0.6643%
CA$
221.63B Market Cap
17.2 P/E Ratio
0.42% Div Yield
544 Volume
6.22 Eps
CA$ 25.59
Previous Close Want to track GILD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gilead Sciences Inc. CDR (GILD) Statistics
Valuation metrics
Market Cap 221.63B
Enterprise value 67.02B
Trailing P/E (ttm) 19.8
Forward P/E -
PEG ratio 0.86
Price/Sales (ttm) 7.62
Price/Book (mrq) 1.1
Enterprise Value/Revenue 1.68
Enterprise Value/EBITDA 3.45
Overview
Shares outstanding 1.24B
Float 1.24B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 18.57K
Average volume (90 days) 7.1K
Price summary
52-Week low 21.87
52-Week high 31.8
Beta 0.33
50-Day moving average 25.75
200-Day moving average 23.98
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.28%
Operating margin 0.45%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.41%
Income Statement
Revenue (ttm) 40.01B
Revenue per share (ttm) 23.35
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 31.49B
EBITDA 14.81B
Net income to common (ttm) 11.16B
Diluted EPS (ttm) 1.33
Quarterly earnings growth (yoy) 1.44%
Balance Sheet
Total cash (mrq) 11.68B
Total cash per share (mrq) 6.84
Total debt (mrq) 34.31B
Total Debt/Equity (mrq) 116.24
Current ratio (mrq) 1.45%
Book value per share (mrq) 23.85
Cash Flow
Cash flow statement 13.3B
Levered free cash flow (LFCF) 11.04B
